Oxford Maternal & Perinatal Health Institute (OMPHI)
The institute was founded in 2009 under the aegis of Green Templeton College, University of Oxford.
It is currently running 4 large, global studies involving over 350 researchers from a wide range of countries.
The Oxford Maternal & Perinatal Health Institute (OMPHI) works alongside Nuffield Department of Women's & Reproductive Health - bringing together world experts to resolve priority maternal and perinatal health problems on a global scale.
what we do
We engage medical researchers, social scientists and health management experts in some of the major issues affecting the health of mothers and newborn babies, particularly in resource-poor settings.
WHO WE ARE
The OMPHI International fellowship is awarded to fellows to develop specific skills relevant to the field of global Maternal & Perinatal Health.
Our research focuses on fetal growth and nutrition and the effects of infection (e.g.malaria) in pregnancy; initiatives aimed at developing e-learning programmes in developing countries, and surveys of healthcare providers in resource-poor settings to identify barriers to implementing effective interventions in pregnancy. Our studies are funded by:
MHTF is a project of the Women and Health Initiative at the Harvard T.H.Chan School of Public Health which works to create a strong, well-informed and integrated community with equitable access to high-quality technical evidence to eliminate preventable maternal mortality and morbidity worldwide. MHTF is led by Ana Langer, a physician specializing in pediatrics and neonatology and a reproductive health expert.
OMPHI also works with The Geneva Foundation for Medical Education and Research on various joint initiatives. GFMER is a non-profit organisation established in 2002. It is supported by the Republic and Canton of Geneva, the Department of Social Affairs of the City of Geneva and other Swiss and international institutions. The Foundation works in close collaboration with the World Health Organization (WHO). GFMER is a WHO Collaborating Centre in Education and Research in Human Reproduction. The overall objectives of the Foundation are to furnish health education and research programmes that can be applied by developing countries, and countries in economic transition, and to establish collaboration between entities from the public and private sectors. See more
An International Fetal and Newborn Growth Consortium dedicated to improving perinatal health through the development of new fetal and newborn growth standards, providing tools for the continuity of care from conception to 5 years of age. It is a global, multidisciplinary network of more than 300 researchers and clinicians from 27 institutions in 18 countries worldwide, coordinated from the University of Oxford. It was launched in 2008 by José Villar & Stephen Kennedy to challenge the assumption that babies inherently grow differently around the world. The project is the largest, population‐based, prospective study of fetal and newborn growth and development ever conducted, involving nearly 60,000 mothers and babies. See more
The INTERBIO-21st Study is an extension to the INTERGROWTH-21st Project. The study aims to improve the phenotypic characterisation of the fetal growth restriction/small for gestational age (FGR/SGA) and preterm birth syndromes at molecular, biochemical and clinical levels so as to develop better strategies to correct the effects of an adverse intrauterine environment.The study is initially focusing on the effects of nutrition on fetal growth and development in healthy and complicated pregnancies from seven different populations worldwide by using epigenetic profiling of cord blood and placental tissues to understand better the causes of the FGR/SGA and preterm birth syndromes. The populations being studied have very different risk profiles as they include some women in resource-poor settings at high risk for FGR/SGA and preterm delivery because of malnutrition and/or infection (HIV and malaria). Standardised information about pregnancy outcomes and anthropometric measurements are also being collected using tools developed in the INTERGROWTH-21stProject.
INTERBIO-21st has two components: the Fetal and Neonatal Studies. In the Fetal Study, which is limited to certain settings, women are being monitored from early pregnancy onwards so as to capture very detailed information about fetal growth patterns; in the Neonatal Study, women are identified at birth provided that gestational age has been confirmed by ultrasound < 24 weeks’ gestation. See more
(a) standardising growth measurement in babies born preterm by using the INTERGROWTH-21st international standards
(b) implementing evidence-based feeding recommendations based on breast feeding.
We have formed partnerships with leading neonatal units across the world to introduce these interventions in their hospitals and countries, with the ultimate aim of wider dissemination and high-level health policy support.
Using recommended feeding practices and international standards to monitor postnatal growth and development should help avoid nutritional patterns that may be associated with childhood overweight and obesity, and improve the growth, development and survival of preterm infants.
The support of the Family Larsson-Rosenquist Foundation’ is gratefully acknowledged.
Collaborators in the INTERPRACTICE Project
Jose Villara, MD, Francesca Giulianib, MD, Fernando Barrosc,d, MD, Paola Roggeroe, MD, Irma Alejandra Coronado Zarcof, MD, Maria Albertina S. Regog, MD, Roseline Ochiengh, MD, Maria Lorella Giannie, MD, Suman Raoi, MD, Ann Lamberta, PhD, Irina Ryuminaj, MD, Carl Brittok, MD, Deepak Chawlal, MD, Leila Cheikh Ismaila, PhD, Syed Rehan Alim, MD, Jane Hirsta, MD, Jagjit Singh Tejin, MD, Karim Abawio, MD, Jacqueline Asibeyp, MD, Josephine Agyeman-Duaho, MSc, Kenny McCormickq, MD, Enrico Bertinor, MD, Aris T Papageorghioua, MD, Josep Figueras-Aloys, MD, Montserrat Izquierdo Renaut Ricardo Nietou MD, Constanza Soto Contiu MD, Gabriela Tavchioskav MD, Alexandre Lapillonnew MD, Zulfiqar Bhuttax PhD, Stephen Kennedya MD, Ana Langery MD.
a Nuffield Department of Women's & Reproductive Health and Oxford Maternal & Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, UK
bAzienda Ospedaliera OIRM Sant’Anna Citta della Salute e della Scienza di Torino, Italy
c Programa de Pós-Graduação em Saúde e Comportamento, Universidade Católica de Pelotas, Pelotas, Brazil
d Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, Brazil
e NICU, Fondazione I.R.C.C.S. "Ca' Granda" Milano, Italy
f Instituto Nacional de Perinatología "Isidro Espinosa de los Reyes", Mexico City, Mexico
g Departmento de Pediatria, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
h The Aga Khan Hospital, Nairobi, Kenya
i St. John's Medical College Hospital, Bangalore, India
j Center for Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation
k Department of Paediatrics, University of Oxford, Oxford, UK
l Government Medical College, Chandigarh, India
m The Aga Khan Hospital, Karachi, Pakistan
n Ann & Robert H. Lurie Children’s Hospital of Chicago and Mercy Hospital and Medical Center, Chicago, Illinois, USA
o Geneva Foundation for Medical Education and Research, Geneva, Switzerland
p Holy Family Hospital, Techiman, Brong Ahafo Region, Ghana
q John Radcliffe Hospital, Headington, Oxford, UK
r Dipartimento di Scienze Pediatriche e dell’Adolescenza, Cattedra di Neonatologia, Università degli Studi di Torino, Torino, Italy
s University of Barcelona, Barcelona, Spain
t Saint Joan de Deu Barcelona Hospital, Barcelona, Spain
uThe Sardá Maternity Hospital, Esteban de Luca 21 51 CABA CP 1246, Buenos Aires, Argentina
vGeneral Hospital ,,Borka Taleski" street ,Trajko Tarcan" bb Prilep 7500 R. Macedonia
wDept of Neonatology, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris
x Center for Global Child Health, Hospital for Sick Children, Toronto, Canada
yHarvard School of Public Health, Boston, MA,USA